Summary auto-generated
This study formally validates Rickettsia helvetica as a distinct species within the spotted fever group of rickettsiae. The organism was originally isolated in 1979 from Ixodes ricinus ticks collected in Switzerland and designated the Swiss agent. Using the type strain C3 and two additional tick isolates (Ix10 and Ix12), researchers confirmed its status through multiple complementary approaches: microimmunofluorescence serologic typing showed no cross-reactivity with other spotted fever group rickettsiae, sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a unique protein profile distinct from all other species examined, and Western blotting with mouse antisera demonstrated species-specific epitopes. Polymerase chain reaction-restriction fragment length polymorphism analysis confirmed its classification as a spotted fever group member. A distinctive characteristic was that R. helvetica disappears from human embryonic lung fibroblast cultures after 1-2 days, unlike other spotted fever rickettsiae. The organism grows in Vero and L929 cells without causing cytopathic effects and shows pathogenicity in certain rodent species. No evidence of actin-based intracellular movement was observed. The authors provide a complete species description and establish strain C3 as the reference type strain, housed at the Reference Center for Rickettsioses in Marseille.
Key findings
- Rickettsia helvetica is a serologically distinct species showing specificity difference values >3 with all other spotted fever group rickettsiae tested
- The organism has a unique protein profile on SDS-PAGE that differs from all other spotted fever group species examined, particularly in high-molecular-weight proteins
- R. helvetica exhibits a characteristic inability to survive in human embryonic lung fibroblast cultures beyond 1-2 days, distinguishing it from other spotted fever rickettsiae
- Polymerase chain reaction analysis confirmed R. helvetica belongs to the spotted fever group, though the 190-kDa protein gene could not be amplified, suggesting unique outer membrane proteins
This summary was generated automatically from the article PDF and is not part of the original publication. Refer to the PDF for the authoritative text.
Abstract
We propose the name Rickettsia helvetica sp. nov. for a rickettsial serotype of unknown pathogenicity isolated in 1979 in Switzerland from Ixodes ricinus ticks and designated the Swiss agent. The growth characteristics and the results of microimmunofluorescence serologic typing, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blotting (immunoblotting) with specific mice sera, and a polymerase chain reaction followed by restriction fragment length polymorphism analysis confirmed previously reported preliminary findings which suggested that this rickettsia, to which a name was given provisionally, does represent a new member of the spotted fever group of rickettsiae. The type strain is C3 (Reference Center for Rickettsioses, Marseille, France).